Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

TWD 27.9

(-0.18%)

Net Income Summary of Chi Sheng Pharma & Biotech Co., Ltd

  • Chi Sheng Pharma & Biotech Co., Ltd's latest annual net income in 2023 was 68.67 Million TWD , down -55.41% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd's latest quarterly net income in 2024 Q1 was 23.12 Million TWD , up 205.56% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported an annual net income of 154 Million TWD in 2022, up 90.72% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported an annual net income of 80.75 Million TWD in 2021, up 36.54% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported a quarterly net income of 20.6 Million TWD for 2024 Q2, down -10.92% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported a quarterly net income of 7.56 Million TWD for 2023 Q4, down -65.35% from previous quarter.

Annual Net Income Chart of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Historical Annual Net Income of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Year Net Income Net Income Growth
2023 68.67 Million TWD -55.41%
2022 154 Million TWD 90.72%
2021 80.75 Million TWD 36.54%
2020 59.14 Million TWD -18.37%
2019 72.45 Million TWD 0.0%

Peer Net Income Comparison of Chi Sheng Pharma & Biotech Co., Ltd

Name Net Income Net Income Difference
St.Shine Optical Co.,Ltd. 545.95 Million TWD 87.421%
Bioteque Corporation 452.55 Million TWD 84.825%
Sunder Biomedical Tech. Co., Ltd. -33.15 Million TWD 307.13%
BenQ Medical Technology Corporation 114.58 Million TWD 40.065%
Pacific Hospital Supply Co., Ltd 420.79 Million TWD 83.68%
Unicon Optical Co., Ltd. 207.73 Million TWD 66.942%
Formosa Optical Technology Co.,Ltd. 417.94 Million TWD 83.569%
Medeon Biodesign, Inc. -1.2 Billion TWD 105.701%
Concord Medical Co., Ltd. 42.74 Million TWD -60.663%
Crystalvue Medical Corporation 103.39 Million TWD 33.582%
Perfect Medical Industry Co., Ltd. 40.08 Million TWD -71.304%
ICARES Medicus, Inc. 97.72 Million TWD 29.73%
Lagis Enterprise Co., Ltd. 64.1 Million TWD -7.127%
Amed Co., Ltd. 91.71 Million TWD 25.123%